Stoke Therapeutics, Inc.STOKNASDAQ

Revenue (LTM)

$184M

+404.5% YoY

Net Income (LTM)

$-7M

+92.3% YoY

Free Cash Flow

$45M

Revenue CAGR (5Y)

—

—Marginsstable

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	12	9↓29.2%	37↑316.3%	184↑404.5%
Gross Profit	0	12	9↓29.2%	37↑316.3%	184↑404.5%
Operating Income	-86	-104↓21.3%	-115↓10.0%	-101↑11.7%	-21↑79.7%
Net Income	-86	-101↓17.8%	-105↓3.6%	-89↑15.0%	-7↑92.3%
EBITDA	-85	-103↓20.8%	-112↓9.2%	-99↑11.7%	-19↑81.0%
EPS Diluted	-2.34	-2.60↓11.1%	-2.38↑8.5%	-1.65↑30.7%	-0.12↑92.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	145	114↓21.6%	191↑68.6%	128↓33.1%	84↓34.2%
Total Current Assets	229	244↑6.5%	215↓11.8%	233↑8.1%	306↑31.3%
Total Assets	239	256↑7.2%	228↓10.8%	272↑18.9%	418↑54.1%
Total Current Liabilities	17	31↑83.2%	31↓1.8%	40↑30.0%	58↑44.5%
Total Liabilities	21	71↑237.7%	69↓3.4%	43↓38.2%	66↑55.1%
Total Equity	218	185↓15.1%	160↓13.7%	229↑43.5%	352↑53.9%
Total Debt	2	2↑56.5%	2↓12.6%	2↑12.6%	0
Net Debt	-143	-111↑22.5%	-189↓70.3%	-126↑33.6%	-84↑33.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-67	-32↑52.4%	-81↓154.4%	-87↓7.1%	46↑152.5%
Capital Expenditure	-1	-4↓230.2%	-2↑59.2%	-0↑87.4%	-1↓230.0%
Free Cash Flow	-68	-36↑47.4%	-83↓130.8%	-87↓5.3%	45↑151.6%
Stock-Based Comp	16	23↑38.9%	25↑10.5%	27↑8.8%	32↑17.4%
Net Change in Cash	-142	-31↑77.9%	78↑348.5%	-63↓181.2%	-44↑30.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance